IRF1 and breast carcinoma: Notably, overexpression of IRF-1 in breast carcinoma cells has been found to result in a 15-fold down-regulation of survivin protein levels [52], which has been attributed to the suppression of cyclin B1, CDK-1, cyclin E, E2F1, CDK2, and CDK4 expression [53].